© 2022 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
June 22, 2022
Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler share practice pearls for HPV and cervical cancer screening and express their hope for emerging testing options.
Experts in obstetric and gynecologic management provide insight on the role of HPV genotypes in cervical cancer risk.
June 15, 2022
Mark H. Stoler, MD, FASCP, provides insight on the role of dual testing in the management of HPV positive women.
Drs Sangini S. Sheth and Mark H. Stoler share their thoughts on the adoption of primary HPV screening and how they foresee changes to cervical cancer screening as more individuals get vaccinated.
June 07, 2022
Thomas C. Wright Jr., MD; Emily K Hill, MD; and Sangini S. Sheth, MD, MPH, FACOG, comment on the impact COVID-19 had on HPV and cervical cancer screening in their respective practices.
Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler, comment on the implementation considerations surrounding HPV and cervical cancer screening.